sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 326-350 out of 1333.

<< < 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 > >>

Public Release: 10-Feb-2017
Nature Communications
Malaria vaccine target's invasion partner uncovered
A team at the Wellcome Trust Sanger Institute has discovered how a promising malarial vaccine target -- the protein RH5 -- helps parasites to invade human red blood cells. Published in Nature Communications, the study reveals that a previously mysterious protein on the surface of the parasite called P113 provides a molecular bridge between the parasite and a red blood cell. The discovery could be used to make a more effective malaria vaccine.
Wellcome Trust, Medical Research Council

Contact: Samantha Wynne
press.office@sanger.ac.uk
122-349-2368
Wellcome Trust Sanger Institute

Public Release: 10-Feb-2017
American Journal of Respiratory and Critical Care Medicine
Chinese air pollution linked to respiratory and cardiovascular deaths
In the largest epidemiological study conducted in the developing world, researchers found that as exposures to fine particulate air pollution in 272 Chinese cities increase, so do deaths from cardiovascular and respiratory diseases.
Public Welfare Research Program of National Health and Family Planning Commission of China, National Science Foundation of China, China Medical Board Collaborating Program

Contact: Dacia Morris
dmorris@thoracic.org
212-315-8620
American Thoracic Society

Public Release: 9-Feb-2017
Science
Why malaria mosquitoes like people with malaria
Malaria mosquitoes prefer to feed -- and feed more -- on blood from people infected with malaria. Researchers from Stockholm University, the Swedish University of Agricultural Sciences and KTH Royal Institute of Technology have discovered why. The findings can lead to new ways to fight malaria without using poisonous chemicals. The results will be published in the next issue of the journal Science.

Contact: Ingrid Faye
ingrid.faye@su.se
46-081-61272
Stockholm University

Public Release: 9-Feb-2017
$2 million grant to speed the development of new vector control products
LSTM's Department of Vector Biology has received a major grant from the Bill & Melinda Gates Foundation for a research programme to develop novel test protocols to accelerate development and bring to market, the next generation of vector control products.
The Bill & Melinda Gates Foundation

Contact: Clare Bebb
clare.bebb@lstmed.ac.uk
44-015-170-53135
Liverpool School of Tropical Medicine

Public Release: 9-Feb-2017
UMass Amherst research may lead to non-surgical cataract treatment
Early phase discoveries by polymer physicist Murugappan Muthukumar at UMass Amherst regarding the fundamental science of proteins in the lens of the human eye could revolutionize treatment of cataract and presbyopia.

Contact: Janet Lathrop
jlathrop@umass.edu
413-545-0444
University of Massachusetts at Amherst

Public Release: 9-Feb-2017
PLOS Computational Biology
Genetics of both virus and patient work together to influence the course of HIV infection
Viral and human genetics together account for about one third of the differences in disease progression rates seen among people infected with the human immunodeficiency virus (HIV), according to new research published in PLOS Computational Biology. The findings suggest that patient genetics influences disease progression by triggering mutations in the HIV viral genome.

Contact: Jacques Fellay
jacques.fellay@epfl.ch
PLOS

Public Release: 8-Feb-2017
Scientific Reports
A 'release and kill' strategy may aid treatment of tuberculosis
Mycobacterium tuberculosis hijacks human macrophages to evade immune destruction while preventing the macrophage from undergoing programmed cell death. This niche lets them grow in a protected environment that is hard to reach with antibiotics. In a proof-of-concept experiment, researchers were able to specifically force M. tuberculosis-infected macrophages into programmed cell death called apoptosis, thereby releasing the sheltered M. tuberculosis bacteria from the macrophage and expose them to a lethal dose of rifampicin antibiotic.
National Institutes of Health

Contact: Jeff Hansen
jeffhans@uab.edu
205-209-2355
University of Alabama at Birmingham

Public Release: 8-Feb-2017
Paediatrics and International Child Health
How Thailand eliminated mother-to-child HIV transmission
Thailand has become the first Asian country to eliminate mother-to-child transmission of HIV, thanks to a pragmatic multi-sector response backed by strong political commitment and heavy government investment, a study published in Paediatrics and International Child Health reports.

Contact: Sayjal Mistry
sayjal.mistry@informa.com
Taylor & Francis Group

Public Release: 7-Feb-2017
Inferface
New study is an advance toward preventing a 'post-antibiotic era'
New UCLA research may help to overcome life-threatening antibiotic-resistant bacteria in what the World Health Organization warns could become a 'post-antibiotic era.' UCLA biologists combined different classes of antibiotics to kill E. coli bacteria in their laboratory and found that certain combinations of three antibiotics are surprisingly effective in killing the bacteria and may be helpful in slowing the evolution of resistance to bacteria.

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles

Public Release: 7-Feb-2017
Dissertations
Malaria control efforts can benefit from forecasting using satellites
Umeå University researcher Maquins Sewe has established links between patterns of malaria in Kenya and environmental factors (temperature, rainfall and land cover) measurable by satellite imagery. In his doctoral dissertation, the researcher shows that conducive environmental conditions occur before increases in hospital admissions and mortality due to malaria, indicating that the satellite information is useful for the development of disease forecasting models and early warning systems.

Contact: Daniel Harju
daniel.harju@umu.se
46-725-522-918
Umea University

Public Release: 6-Feb-2017
Nature Microbiology
Genes linked to malaria parasites' ability to persist in the body
The ability of malaria parasites to persist in the body for years is linked to the expression of a set of genes from the pir gene family, scientists from the Francis Crick Institute and the Wellcome Trust Sanger Institute have found. Their results are published today in Nature Microbiology.
Cancer Research UK, UK Medical Research Council, Wellcome

Contact: Francis Crick Institute press office
press@crick.ac.uk
44-020-379-63095
The Francis Crick Institute

Public Release: 6-Feb-2017
International Journal of Epidemiology
Research finds flaws in studies of mass deworming efforts for children in poor countries
Research published in the International Journal of Epidemiology finds that three widely cited studies relating to mass deworming in Africa have substantial problems in their methods and analysis. The original researchers claimed that their results show long-term effectiveness of these mass deworming programs in developing countries, but this critical analysis concludes that the findings are unlikely to be as positive as previously reported.

Contact: Daniel Luzer
daniel.luzer@oup.com
Oxford University Press USA

Public Release: 5-Feb-2017
Scientific Reports
Queensland-led team develops effective economical Ebola treatment
An effective and economical treatment for Ebola patients has been developed by an international team led by Queensland researchers. The post-exposure treatment made with antibodies from horses could be used in the next Ebola outbreak.
Australian Infectious Diseases Research Centre

Contact: Alexander Khromykh
a.khromykh@uq.edu.au
61-733-467-219
University of Queensland

Public Release: 3-Feb-2017
Circulation
Number of children emerging as cardiovascular risk factor for both parents
Number of children is emerging as a novel factor that influences the risk for some cardiovascular diseases (CVD), and in some societies in both parents, according to Professor Vera Regitz-Zagrosek, chairperson of the European Society of Cardiology 'management of CVD During Pregnancy' guidelines task force.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 2-Feb-2017
PLOS Genetics
Scaled-up malaria control efforts breed insecticide resistance in mosquitoes
A genetic analysis of mosquito populations in Africa shows that recent successes in controlling malaria through treated bednets has led to widespread insecticide resistance in mosquitoes, according to a study led by Charles Wondji of the Liverpool School of Tropical Medicine, with Kayla Barnes, Gareth Weedall and colleagues in PLOS Genetics.

Contact: Charles Wondji
charles.wondji@lstmed.ac.uk
PLOS

Public Release: 1-Feb-2017
Journal of Virology
Scientists prove new approach to Polio vaccines works
Scientists have identified new ways to provide vaccines against polio, which do not require the growth of live virus for their manufacture.
World Health Organisation

Contact: Peter Le Riche
p.leriche@leeds.ac.uk
44-113-343-2049
University of Leeds

Public Release: 1-Feb-2017
JAMA Cardiology
Study adds to evidence that electronic cigarettes are not harmless
A study published in JAMA Cardiology has added to growing evidence that electronic cigarettes (e-cigarettes) are not harmless.

Contact: ESC Press Office
press@escardio.org
European Society of Cardiology

Public Release: 1-Feb-2017
Nature Communications
Cocktail of bacteria-killing viruses prevents cholera infection in animal models
Oral administration of a cocktail of three viruses, all of which specifically kill cholera bacteria, protects against infection and prevents cholera-like symptoms in animal model experiments. The findings are the first to demonstrate the efficacy of a preventative, oral phage therapy.
National Institutes of Health

Contact: Kevin Jiang
Kevin.Jiang@tufts.edu
617-636-3728
Tufts University, Health Sciences Campus

Public Release: 1-Feb-2017
Lancet Infectious Diseases
Malaria superbugs threaten global malaria control
A lineage of multidrug resistant P. falciparum malaria superbugs has widely spread and is now established in parts of Thailand, Laos and Cambodia, causing high treatment failure rates for the main falciparum malaria medicines, artemisinin combination therapies (ACTs), according to a study published today in The Lancet Infectious Diseases.
Wellcome Trust

Contact: Andrea Stewart
andrea.stewart@ndm.ox.ac.uk
44-752-813-2489
Infectious Diseases Data Observatory

Public Release: 1-Feb-2017
Organic Process Research & Development
A cheaper way to make a WHO-designated essential medicine
A fungal form of meningitis leads to more than 600,000 deaths in Africa every year and is responsible for 20 percent of HIV/AIDS-related deaths globally, according to the US Centers for Disease Control and Prevention. An existing medicine could help curb these numbers, but its cost has been a barrier to access in some places. Now, scientists report in the ACS journal Organic Process Research & Development a more affordable way to make the drug.

Contact: Katie Cottingham
k_cottingham@acs.org
301-775-8455
American Chemical Society

Public Release: 30-Jan-2017
Proceedings of the National Academy of Sciences
Researchers identify mechanism in chikungunya virus that controls infection and severity
Researchers led by the Johns Hopkins Bloomberg School of Public Health have identified a mechanism by which the chikungunya virus infects healthy cells and controls how severe the disease it causes will be, a mechanism they believe can be found in a number of other related viruses for which there are no treatments or licensed vaccines.
Johns Hopkins Catalyst Award, Journal of Cell Science Travelling Fellowship, Fulbright-Nehru Academic and Professional Excellence Fellowship, Netherlands Organization for Scientific Research

Contact: Stephanie Desmon
sdesmon1@jhu.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health

Public Release: 26-Jan-2017
NIH awards MSU researcher $8.4 million to develop first malaria treatments
While the world waits for a vaccine against the ancient disease malaria, MSU Professor Terrie E. Taylor is using an $8.4 million NIH grant to save the lives of children who are currently afflicted by the deadliest form of the disease.
NIH/National Institute of Allergy and Infectious Diseases, National Institutes of Health

Contact: Jessi Adler
jessi.adler@cabs.msu.edu
517-355-6469
Michigan State University

Public Release: 25-Jan-2017
Agricultural fires in Brazil harm infant health, a warning for the developing world
Exposure to pollution from agricultural fires in the last few months of gestation leads to earlier birth and smaller babies, researchers at Princeton and Duke universities have found. The results offer a warning to the developing world, where such fires are common.
National Institutes of Health

Contact: Michael Hotchkiss
michaelhotchkiss@gmail.com
609-258-9522
Princeton University

Public Release: 25-Jan-2017
Lancet Infectious Diseases
Major drug initiatives are best way to curb threat from parasites
Large-scale programmes to treat a life-threatening disease could improve the health of millions despite concerns about their long-term effects, a study suggests.

Contact: Corin Campbell
Corin.Campbell@ed.ac.uk
44-131-650-6382
University of Edinburgh

Public Release: 25-Jan-2017
Bill & Melinda Gates Foundation boosts vital work of the University of Washington's IHME
The Bill & Melinda Gates Foundation and University of Washington's Institute for Health Metrics and Evaluation (IHME) announced today the foundation's commitment to invest $279 million in IHME to expand its work over the next decade.
Bill & Melinda Gates Foundation

Contact: Kayla Albrecht
albrek7@uw.edu
206-897-3792
Institute for Health Metrics and Evaluation

Showing releases 326-350 out of 1333.

<< < 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 > >>